Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Do patients participating in clinical trials want to know study results?
Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Partridge AH, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):491-2. doi: 10.1093/jnci/95.6.491. J Natl Cancer Inst. 2003. PMID: 12644548 No abstract available.
Adherence to therapy with oral antineoplastic agents.
Partridge AH, Avorn J, Wang PS, Winer EP. Partridge AH, et al. J Natl Cancer Inst. 2002 May 1;94(9):652-61. doi: 10.1093/jnci/94.9.652. J Natl Cancer Inst. 2002. PMID: 11983753 Review.
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Partridge AH, et al. J Natl Cancer Inst. 2004 Apr 21;96(8):629-32. doi: 10.1093/jnci/djh096. J Natl Cancer Inst. 2004. PMID: 15100341
Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.
Katz ML, Archer LE, Peppercorn JM, Kereakoglow S, Collyar DE, Burstein HJ, Schilsky RL, Partridge AH. Katz ML, et al. Among authors: partridge ah. Cancer. 2012 Oct 1;118(19):4801-5. doi: 10.1002/cncr.27485. Epub 2012 Mar 5. Cancer. 2012. PMID: 22392584
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study.
Vaz-Luis I, Barroso-Sousa R, Di Meglio A, Hu J, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, O'Neil K, Partridge A, Burstein H, Waks AG, Trippa L, Tolaney SM, Hassett M, Winer EP, Lin NU. Vaz-Luis I, et al. Among authors: partridge a. J Clin Oncol. 2020 Jul 20;38(21):2390-2397. doi: 10.1200/JCO.19.02484. Epub 2020 Apr 24. J Clin Oncol. 2020. PMID: 32330102
Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
Magbanua MJM, Savenkov O, Asmus EJ, Ballman KV, Scott JH, Park JW, Dickler M, Partridge A, Carey LA, Winer EP, Rugo HS. Magbanua MJM, et al. Among authors: partridge a. Clin Cancer Res. 2020 Jun 25. doi: 10.1158/1078-0432.CCR-20-1329. Online ahead of print. Clin Cancer Res. 2020. PMID: 32586939
Offering participants results of a clinical trial: sharing results of a negative study.
Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP. Partridge AH, et al. Lancet. 2005 Mar 12-18;365(9463):963-4. doi: 10.1016/S0140-6736(05)71085-0. Lancet. 2005. PMID: 15766998
238 results
Jump to page
Feedback